Evidence map›Paper›PMID 16207327›Full record

ArticleArthritis research & therapy2005

Local hyperemia to heating is impaired in secondary Raynaud's phenomenon.

Aude Boignard, Muriel Salvat-Melis, Patrick H Carpentier, Christopher T Minson, Laurent Grange, Catherine Duc, Françoise Sarrot-Reynauld, Jean-Luc Cracowski

Registry-linked trialOpen access · goldAbstract readComparative Study
In one paragraph

Article in Arthritis research & therapy, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02549534 (Early Detection of Taxane-Induced Neuropathy in Women With Breast Cancer), which is not on this map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02549534 completednot on this mapstarted 2015, after this paper: background citation

Early Detection of Taxane-Induced Neuropathy in Women With Breast Cancer

TypeobservationalSponsorIndiana UniversityRan2015 to 2016Enrolled29ConditionsPeripheral NeuropathyArmsAxon Reflexes, Axon Flares, Self-Reported Signs & Symptoms of CIPN
3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 69 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. New perspectives in the imaging of Raynaud's phenomenon.European journal of rheumatology · 2020
    Review
  6. Article
  7. Article
  8. Article
  9. Prolonged postocclusive hyperemia response in patients with normal-tension glaucoma.Medical science monitor : international medical journal of experimental and clinical research · 2014
    Article
  10. Article
  11. Review
  12. Article
  13. Peripheral mechanisms of thermoregulatory control of skin blood flow in aged humans.Journal of applied physiology (Bethesda, Md. : 1985) · 2010
    Review
  14. Thermal provocation to evaluate microvascular reactivity in human skin.Journal of applied physiology (Bethesda, Md. : 1985) · 2010
    Review
  15. Aging and the control of human skin blood flow.Frontiers in bioscience (Landmark edition) · 2010
    Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Aude BoignardLaboratory HP2, EA 3745 Inserm ESPRI, Grenoble Medical School, France.
Muriel Salvat-Melis
Patrick H Carpentier
Christopher T Minson
Laurent Grange
Catherine Duc
Françoise Sarrot-Reynauld
Jean-Luc Cracowski
Centre Hospitalier Universitaire de Grenoble · FRInserm · FRUniversité Grenoble Alpes · FRUniversity of Oregon · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Accurate and sensitive measurement techniques are a key issue in the quantification of the microvascular and endothelial dysfunction in systemic sclerosis (SSc). Thermal hyperemia comprises two separate mechanisms: an initial peak that is axon reflex mediated; and a sustained plateau phase that is nitric oxide dependent. The main objective of our study was to test whether thermal hyperemia in patients with SSc differed from that in patients with primary Raynaud's phenomenon (RP) and healthy controls. In a first study, we enrolled 20 patients suffering from SSc, 20 patients with primary RP and 20 healthy volunteers. All subjects were in a fasting state. Post-occlusive hyperemia, 0.4 mg sublingual nitroglycerin challenge and thermal hyperemia were performed using laser Doppler flowmetry on the distal pad of the third left finger. In a second study, thermal hyperemia was performed in 10 patients with rheumatoid arthritis and 10 patients with primary RP. The thermal hyperemia was dramatically altered in terms of amplitude and kinetics in patients with SSc. Whereas 19 healthy volunteers and 18 patients with primary RP exhibited the classic response, including an initial peak within the first 10 minutes followed by a nadir and a second peak, this occurred only in four of the SSc patients (p < 0.0001). The 10 minutes thermal peak was 43.4 (23.2 to 63), 42.6 (31 to 80.7) and 27 (14.7 to 51.4) mV/mm Hg in the healthy volunteers, primary RP and SSc groups, respectively (p = 0.01), while the 44 degrees C thermal peak was 43.1 (21.3 to 62.1), 42.6 (31.6 to 74.3) and 25.4 (15 to 52.4) mV/mm Hg, respectively (p = 0.01). Thermal hyperemia was more sensitive and specific than post-occlusive hyperhemia for differentiating SSc from primary RP. In patients with rheumatoid arthritis, thermal hyperemia was also altered in terms of amplitude. Thermal hyperemia is dramatically altered in patients with secondary RP in comparison with subjects with primary RP. Further studies are required to determine the mechanisms of this altered response, and whether it may provide additional information in a clinical setting.

Indexed as

Hot TemperatureAdultCell CountCohort StudiesEndothelium, VascularFemaleFingersHumansHyperemiaKineticsLaser-Doppler FlowmetryMaleMiddle AgedModels, BiologicalNitric OxideNitroglycerinNitric OxideNitroglycerinVasodilator Agents

Identifiers

PMID16207327
PMCPMC1257434
OpenAlexW2153262580

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.